Zhu Y - Search Results

1

PKCα in colon cancer cells promotes M1 macrophage polarization via MKK3/6-P38 MAPK pathway.

Cheng Y, Zhu Y, Xu W, Xu J, Yang M, Chen P, Zhao J, Geng L, Gong S. Cheng Y, et al. Among authors: zhu y. Mol Carcinog. 2018 Aug;57(8):1017-1029. doi: 10.1002/mc.22822. Epub 2018 May 2. Mol Carcinog. 2018. PMID: 29637628

2

[Effect of Biejiajian Pills on Wnt/β-catenin signal pathway and DKK-1 and FrpHe gene expressions in hepatocellular carcinoma cells].

He S, Cheng Y, Zhu Y, Fan Q, Sun H, Jia W. He S, et al. Among authors: zhu y. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jan;33(1):30-3. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 23353151 Chinese.

3

[Blejiajian pill inhibited the proliferation, adhesion, and invasion of hepatoma carcinoma cells: an experimental research].

Cheng Y, He SQ, Zhu Y, Fan Q, Yang S, Chen R. Cheng Y, et al. Among authors: zhu y. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 May;33(5):664-7. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013. PMID: 23905388 Chinese.

4

[Therapeutic effect of sorafenib on portal hypertension: research progress and mechanisms].

Zhu Y, Cheng Y, Li A, Luo R. Zhu Y, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):133-6. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24463135 Review. Chinese.

5

Aspirin for the primary prevention of skin cancer: A meta-analysis.

Zhu Y, Cheng Y, Luo RC, Li AM. Zhu Y, et al. Oncol Lett. 2015 Mar;9(3):1073-1080. doi: 10.3892/ol.2015.2853. Epub 2015 Jan 7. Oncol Lett. 2015. PMID: 25663859 Free PMC article.

6

Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.

Cheng Y, Zhu Y, Huang X, Zhang W, Han Z, Liu S. Cheng Y, et al. Among authors: zhu y. PLoS One. 2015 May 29;10(5):e0126803. doi: 10.1371/journal.pone.0126803. eCollection 2015. PLoS One. 2015. PMID: 26023918 Free PMC article.

7

Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma.

Zhu Y, Cheng Y, Guo Y, Chen J, Chen F, Luo R, Li A. Zhu Y, et al. Oncotarget. 2016 Feb 2;7(5):5327-41. doi: 10.18632/oncotarget.6633. Oncotarget. 2016. PMID: 26683365 Free PMC article.

8

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.

Cheng Y, Luo R, Zheng H, Wang B, Liu Y, Liu D, Chen J, Xu W, Li A, Zhu Y. Cheng Y, et al. Among authors: zhu y. Oncotarget. 2017 Apr 4;8(14):23265-23276. doi: 10.18632/oncotarget.15575. Oncotarget. 2017. PMID: 28423574 Free PMC article.

9

PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.

Cheng Y, Zhu Y, Xu J, Yang M, Chen P, Xu W, Zhao J, Geng L, Gong S. Cheng Y, et al. Among authors: zhu y. Mol Cancer. 2018 Jan 24;17(1):13. doi: 10.1186/s12943-017-0747-z. Mol Cancer. 2018. PMID: 29368606 Free PMC article.

10

Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway.

Cheng Y, Zheng H, Wang B, Xu W, Xu J, Zhu Y. Cheng Y, et al. Among authors: zhu y. Dig Liver Dis. 2018 Apr;50(4):381-388. doi: 10.1016/j.dld.2017.12.015. Epub 2017 Dec 28. Dig Liver Dis. 2018. PMID: 29373239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,767 results

Search Page

Filters